Sivelestat sodium
Sivelestat sodium is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment of ARDS With Sivelestat Sodium
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS
Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19
Clinical Trials (9)
Treatment of ARDS With Sivelestat Sodium
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS
Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19
Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis
Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
Improvement of Pulmonary Insufficiency After Aortic Dissection With Sivelestat Sodium
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9